Literature DB >> 18558630

Overlapping and distinct roles for PI3Kbeta and gamma isoforms in S1P-induced migration of human and mouse endothelial cells.

Regine Heller1, Qing Chang, Gunter Ehrlich, Sherry N Hsieh, Simone M Schoenwaelder, Peter J Kuhlencordt, Klaus T Preissner, Emilio Hirsch, Reinhard Wetzker.   

Abstract

AIMS: Sphingosine-1-phosphate (S1P), a key regulator of vascular homeostasis and angiogenesis, promotes endothelial cell migration via stimulation of phosphoinositide 3-kinase (PI3K). The aim of this study was to identify the role of PI3Kbeta and gamma isoforms and their downstream effector pathways in mediating endothelial cell migration induced by S1P. METHODS AND
RESULTS: Experiments were performed in human umbilical vein endothelial cells (HUVEC) and murine lung endothelial cells (MLEC). A combination of specific inhibitors, RNA interference, and PI3Kgamma(-/-) mice were used to investigate the role of PI3Kbeta and gamma isoforms in endothelial cell migration. Both PI3Kbeta and gamma isoforms are required for full migration induced by S1P, with Rac1 being a major mediator downstream of both isoforms. In addition, PI3Kbeta but not PI3Kgamma mediates migration via Akt but independent of Rac1 and endothelial NO synthase (eNOS). Further, a S1P-mediated activation of extracellular signal-regulated kinases (Erk) 1/2 contributes to the chemotactic response independent of PI3Kbeta or PI3Kgamma.
CONCLUSIONS: Our data demonstrate that both PI3Kbeta and PI3Kgamma isoforms are required for S1P-induced endothelial cell migration through activation of Rac1. In addition, PI3Kbeta initiates an Akt-sensitive chemotactic response which is independent of Rac1 and eNOS. Thus, PI3Kbeta and PI3Kgamma have both overlapping and distinct roles in regulating endothelial cell migration, which may underlie S1P-triggered angiogenic differentiation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18558630     DOI: 10.1093/cvr/cvn159

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  19 in total

1.  Discovery of a Potent, Selective, and Orally Available PI3Kδ Inhibitor for the Treatment of Inflammatory Diseases.

Authors:  Montse Erra; Joan Taltavull; Angelique Gréco; Francisco Javier Bernal; Juan Francisco Caturla; Jordi Gràcia; María Domínguez; Mar Sabaté; Stéphane Paris; Salomé Soria; Begoña Hernández; Clara Armengol; Judit Cabedo; Mónica Bravo; Elena Calama; Montserrat Miralpeix; Martin D Lehner
Journal:  ACS Med Chem Lett       Date:  2016-11-30       Impact factor: 4.345

2.  CXCL12-mediated murine neural progenitor cell movement requires PI3Kβ activation.

Authors:  Borja L Holgado; Laura Martínez-Muñoz; Juan Antonio Sánchez-Alcañiz; Pilar Lucas; Vicente Pérez-García; Gema Pérez; José Miguel Rodríguez-Frade; Marta Nieto; Oscar Marín; Yolanda R Carrasco; Ana C Carrera; Manuel Alvarez-Dolado; Mario Mellado
Journal:  Mol Neurobiol       Date:  2013-04-19       Impact factor: 5.590

3.  Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease.

Authors:  Tae-Hyun Yoo; Christopher E Pedigo; Johanna Guzman; Mayrin Correa-Medina; Changli Wei; Rodrigo Villarreal; Alla Mitrofanova; Farah Leclercq; Christian Faul; Jing Li; Matthias Kretzler; Robert G Nelson; Markku Lehto; Carol Forsblom; Per-Henrik Groop; Jochen Reiser; George William Burke; Alessia Fornoni; Sandra Merscher
Journal:  J Am Soc Nephrol       Date:  2014-06-12       Impact factor: 10.121

4.  Effect of hyperglycemia on human monocyte activation.

Authors:  Debashis Nandy; Rajiv Janardhanan; Debabrata Mukhopadhyay; Ananda Basu
Journal:  J Investig Med       Date:  2011-04       Impact factor: 2.895

5.  Key role of PI3Kγ in monocyte chemotactic protein-1-mediated amplification of PDGF-induced aortic smooth muscle cell migration.

Authors:  A Fougerat; N F Smirnova; S Gayral; N Malet; E Hirsch; M P Wymann; B Perret; L O Martinez; M Douillon; M Laffargue
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

6.  Activation of AMP-activated protein kinase by vascular endothelial growth factor mediates endothelial angiogenesis independently of nitric-oxide synthase.

Authors:  Nadine Stahmann; Angela Woods; Katrin Spengler; Amanda Heslegrave; Reinhard Bauer; Siegfried Krause; Benoit Viollet; David Carling; Regine Heller
Journal:  J Biol Chem       Date:  2010-02-03       Impact factor: 5.157

7.  Involvement of phosphoinositide 3-kinase gamma in angiogenesis and healing of experimental myocardial infarction in mice.

Authors:  Mauro Siragusa; Rajesh Katare; Marco Meloni; Federico Damilano; Emilio Hirsch; Costanza Emanueli; Paolo Madeddu
Journal:  Circ Res       Date:  2010-01-07       Impact factor: 17.367

Review 8.  Novel aspects of the roles of Rac1 GTPase in the cardiovascular system.

Authors:  Naoki Sawada; Yuxin Li; James K Liao
Journal:  Curr Opin Pharmacol       Date:  2010-01-07       Impact factor: 5.547

9.  Endothelial and cardiomyocyte PI3Kβ divergently regulate cardiac remodelling in response to ischaemic injury.

Authors:  Xueyi Chen; Pavel Zhabyeyev; Abul K Azad; Wang Wang; Rachel A Minerath; Jessica DesAulniers; Chad E Grueter; Allan G Murray; Zamaneh Kassiri; Bart Vanhaesebroeck; Gavin Y Oudit
Journal:  Cardiovasc Res       Date:  2019-07-01       Impact factor: 10.787

Review 10.  Role of PI3K/Akt signaling pathway in cardiac fibrosis.

Authors:  Wuming Qin; Linghui Cao; Isaac Yaw Massey
Journal:  Mol Cell Biochem       Date:  2021-07-10       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.